Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

Newly developed halide perovskite nanocrystals (HPNCs) show potential as antimicrobial agents that are stable, effective and ...

Children under five years of age, especially those aged two years or under, face a high risk of pneumococcal disease, which ...

Design tool for Custom dPCR Microbial Assays - The first-of-its-kind custom assay design tool enables users to design primers ...

"The blood-brain barrier is an essential defense mechanism, but it also presents a significant challenge for delivering drugs ...

Pathogen genomic surveillance analyzes the genetic code of viruses, bacteria, and other pathogens to understand how they ...

For decades, scientists have studied animals living in or near the Chernobyl Nuclear Power Plant to see how increased levels ...

Effective immunity hinges on the ability to sense infection and cellular transformation. In humans, there is a specialized ...

Abbott announced the launch of its Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over six weeks of age.

“A strain refers to a genetic or structural variant or subtype of a microorganism. The PCV-14 terminology in Abbott’s ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.